Health Reference Library

How does vitamin D deficiency affect sleep and circadian rhythm?

Last reviewed 2 May 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

Observational evidence consistently associates vitamin D deficiency with poorer sleep (Gao 2018, PMID 30275418, OR 1.5-1.7 across 9 studies, n=9,397). Intervention trials show small effects with low certainty of evidence (Abboud 2022). Threshold most associated: 25(OH)D below 50 nmol/L. Mechanistic basis: VDR in CNS sleep-wake regions, modulation of serotonin synthesis and inflammatory cytokines. NHS first-line for chronic insomnia is sleep hygiene, CBT-I, and clinical evaluation, not vitamin D supplementation alone.

How it works

The popular claim of VDR specifically in the suprachiasmatic nucleus (the master circadian clock) is not as cleanly established as the broader CNS distribution; current evidence supports VDR in regions involved in sleep-wake regulation more broadly than specifically in SCN. The p21-as-sleep-protein claim sometimes cited in older summaries is incorrect: p21 is a cell-cycle regulator with no recognised sleep-regulatory role.

Effective dose

The Gao 2018 meta-analysis (PMID 30275418, 9 studies, n=9,397) found vitamin D deficiency associated with sleep disorders (OR 1.50, 95% CI 1.31-1.72), poor sleep quality (OR 1.59), short sleep duration (OR 1.74), and excessive sleepiness (OR 1.36). The 25(OH)D below 50 nmol/L threshold appeared most consistently. Mendelian randomisation evidence (NHANES 2011-2016 published in Sleep and Breathing 2024) has been more equivocal on causality. The observational signal is consistent but does not establish causal direction.

Forms compared

Where vitamin D is taken with a fat-containing meal for absorption (see entry 089dd947), meal timing is the practical anchor rather than sleep-specific timing considerations.

Timing

Practical position: most adults taking standard daily supplementation will not notice a clinically meaningful timing effect; if individual experience suggests a problem with evening dosing, morning dosing is a reasonable default. Routine retesting of 25(OH)D in asymptomatic responders is not recommended (Demay 2024); retest at 12-16 weeks if response is uncertain or symptoms persist.

Safety profile

Hypercalcaemia, sarcoidosis, and kidney stones require clinical assessment before high-dose supplementation regardless of sleep concerns. The Burt 2019 (PMID 31454046) signal of bone harm at sustained intakes above 4,000 IU/day applies to non-deficient populations and is unrelated to sleep-specific use cases.

Special populations

Obstructive sleep apnoea (OSA) is independently associated with low vitamin D status (Neighbors 2018 Sleep Med 43:100-108 and other meta-analyses). Causal direction likely runs primarily from OSA and the obesity that often accompanies it toward worse vitamin D status (reduced outdoor activity, sequestration in adipose tissue) rather than vitamin D deficiency causing OSA. OSA assessment is appropriate where loud snoring, witnessed apnoea, daytime sleepiness, or obesity are present. Vitamin D supplementation does not address OSA.

Interactions

In adults with both low magnesium and low vitamin D, addressing both is more likely to produce a clinically meaningful sleep effect than addressing either alone. The combined approach is an inference from separate evidence bases rather than direct trial evidence on the combination. See entry b9aee79e for rate-of-rise expectations after starting supplementation.

Guideline positions

The major UK guidance bodies do not list vitamin D as an insomnia intervention. NICE NG198 (chronic insomnia) and the British Association for Psychopharmacology (BAP 2019 sleep disorders consensus) anchor on CBT-I, sleep hygiene, and selective short-term hypnotic use. Vitamin D fits within general nutritional sufficiency rather than insomnia-specific care.

Practical framework

Wearable-data context: chronically low deep-sleep percentages alongside winter fatigue is a pattern that warrants broader work-up rather than a single-nutrient explanation. Possible contributors include vitamin D status, iron and ferritin (see entry 9eab0070), thyroid function, alcohol intake, sleep apnoea, and depression. Vitamin D is one variable in this work-up, not the default explanation. For darker-skinned UK populations carrying higher baseline deficiency risk, year-round 10 mcg supplementation is appropriate per NHS guidance regardless of sleep symptoms specifically. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: that p21 is a sleep-related protein modulated by vitamin D. This is incorrect; p21 is a cell-cycle regulator with no recognised sleep-regulatory role. The Gao 2018 observational signal is real but does not establish causal direction; OSA-driven low vitamin D is a likely confounder explaining part of the cross-sectional association.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Sources

  1. Gao Q, Kou T, Zhuang B, Ren Y, Dong X, Wang Q 2018. The Association between Vitamin D Deficiency and Sleep Disorders: A Systematic Review and Meta-Analysis. Nutrients. PMID: 30275418 · DOI: 10.3390/nu10101395
  2. Abboud M 2022. Vitamin D Supplementation and Sleep: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. PMID: 35268051 · DOI: 10.3390/nu14051076
  3. McCarty DE, Chesson AL Jr, Jain SK, Marino AA 2014. The link between vitamin D metabolism and sleep medicine. Sleep Medicine Reviews. PMID: 24075129 · DOI: 10.1016/j.smrv.2013.07.001
  4. Stumpf WE, Bidmon HJ, Li L, Pilgrim C, Bartke A, Mayerhofer A, Heiss C 1992. Nuclear receptor sites for vitamin D-soltriol in midbrain and hindbrain of Siberian hamster (Phodopus sungorus) assessed by autoradiography. Histochemistry. PMID: 1333462 · DOI: 10.1007/BF00315874
  5. NHS UK. Vitamin D. NHS UK (UK government).
  6. Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, Lips P, Mitchell DM, Murad MH, Powers S, Rao SD, Scragg R, Tayek JA, Valent AM, Walsh JME, McCartney CR 2024. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. PMID: 38828931 · DOI: 10.1210/clinem/dgae290

Related entries

Back to Vitamin D overview